Search Results

There are 21867 results for: content related to: Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies

  1. Nail Psoriasis, the unknown burden of disease

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1690–1695, K.M.G. Klaassen, P.C.M. van de Kerkhof and M.C. Pasch

    Article first published online : 15 JAN 2014, DOI: 10.1111/jdv.12368

  2. A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 2, February 2015, Pages: 249–254, G.E. Kim, E. Seidler and A.B. Kimball

    Article first published online : 31 MAR 2014, DOI: 10.1111/jdv.12503

  3. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 7, July 2015, Pages: 1415–1420, M.J. Simpson, C. Chow, H. Morgenstern, T.A. Luger and C.N. Ellis

    Article first published online : 27 APR 2015, DOI: 10.1111/jdv.12861

  4. Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 7, July 2015, Pages: 1302–1309, M. Peppelman, K.P. Nguyen, L. Hoogedoorn, P.E.J. van Erp and M.-J.P. Gerritsen

    Article first published online : 30 OCT 2014, DOI: 10.1111/jdv.12806

  5. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 619–644, C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, L. Matusiak, E.P. Prens, J. Revuz, S. Schneider-Burrus, J.C. Szepietowski, H.H. van der Zee and G.B.E. Jemec

    Article first published online : 30 JAN 2015, DOI: 10.1111/jdv.12966

  6. Sexual dysfunction in psoriasis: a systematic review

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 649–655, A. Molina-Leyva, J.J. Jiménez-Moleón, R. Naranjo-Sintes and J.C. Ruiz-Carrascosa

    Article first published online : 26 NOV 2014, DOI: 10.1111/jdv.12845

  7. Chronic stress experience and burnout syndrome have appreciable influence on health-related quality of life in patients with psoriasis

    Journal of the European Academy of Dermatology and Venereology

    K. Breuer, F.M. Göldner, B. Jäger, T. Werfel and G. Schmid-Ott

    Article first published online : 2 MAR 2015, DOI: 10.1111/jdv.12999

  8. Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 6, June 2014, Pages: 790–798, K.A. Papp, M. Sundaram, Y. Bao, D.A. Williams, Y. Gu, J.E. Signorovitch, Y. Wang, J.M. Valdes and P.M. Mulani

    Article first published online : 17 MAY 2013, DOI: 10.1111/jdv.12177

  9. Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 7, July 2015, Pages: 1398–1405, F. Rencz, P. Holló, S. Kárpáti, M. Péntek, É. Remenyik, A. Szegedi, O. Balogh, E. Herédi, K. Herszényi, H. Jókai, V. Brodszky and L. Gulácsi

    Article first published online : 10 DEC 2014, DOI: 10.1111/jdv.12884

  10. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 3, March 2015, Pages: 452–456, D. Hägg, A. Sundström, M. Eriksson and M. Schmitt-Egenolf

    Article first published online : 9 JUN 2014, DOI: 10.1111/jdv.12576

  11. Tertiary individual prevention improves mental health in patients with severe occupational hand eczema

    Journal of the European Academy of Dermatology and Venereology

    K. Breuer, S.M. John, F. Finkeldey, D. Boehm, C. Skudlik, B. Wulfhorst, C. Dwinger, T. Werfel, T.L. Diepgen and G. Schmid-Ott

    Article first published online : 4 FEB 2015, DOI: 10.1111/jdv.12975

  12. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 2, February 2015, Pages: 353–360, D. Thaçi, K. Unnebrink, M. Sundaram, S. Sood and Y. Yamaguchi

    Article first published online : 21 MAY 2014, DOI: 10.1111/jdv.12553

  13. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 6, June 2015, Pages: 1114–1120, U. Mrowietz, E.N. Chouela, L. Mallbris, D. Stefanidis, V. Marino, R. Pedersen and R. L. Boggs

    Article first published online : 5 NOV 2014, DOI: 10.1111/jdv.12761

  14. PASI90 response: the new standard in therapeutic efficacy for psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 645–648, L. Puig

    Article first published online : 4 NOV 2014, DOI: 10.1111/jdv.12817

  15. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 5, May 2014, Pages: 581–589, K. Papp, Y. Poulin, A. Vieira, J. Shelton and M. Poulin-Costello

    Article first published online : 7 MAR 2013, DOI: 10.1111/jdv.12138

  16. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 789–796, A. Thielitz, A. Lux, A. Wiede, S. Kropf, E. Papakonstantinou and H. Gollnick

    Article first published online : 14 NOV 2014, DOI: 10.1111/jdv.12823

  17. Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients – a randomized placebo-controlled trial

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 3, March 2015, Pages: 555–559, A. Faurschou, M. Gyldenløve, U. Rohde, J.P. Thyssen, C. Zachariae, L. Skov, F.K. Knop and T. Vilsbøll

    Article first published online : 20 AUG 2014, DOI: 10.1111/jdv.12629

  18. Diagnostic accuracy and cost-effectiveness of dermoscopy in primary care: a cluster randomized clinical trial

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 11, November 2014, Pages: 1442–1449, C.J.L. Koelink, K.M. Vermeulen, B.J. Kollen, G.H. de Bock, J.H. Dekker, M.F. Jonkman and W.K. van der Heide

    Article first published online : 7 NOV 2013, DOI: 10.1111/jdv.12306

  19. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 7, July 2014, Pages: 900–906, D. Thaçi, R. Galimberti, M. Amaya-Guerra, T. Rosenbach, D. Robertson, R. Pedersen, S. Yang, M. Kuligowski and R. Boggs

    Article first published online : 15 JUL 2013, DOI: 10.1111/jdv.12207

  20. Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 2, February 2014, Pages: 192–203, C. Mamolo, J. Harness, H. Tan and A. Menter

    Article first published online : 7 JAN 2013, DOI: 10.1111/jdv.12081